"For the majority of people with advanced EGFR-mutated NSCLC, we have highly effective targeted treatment options. However, for a minority with EGFR exon 20-mutated disease, these treatments don’t ...
Disparities in the prevalence of EGFR mutations and ALK rearrangements by racial-ethnic group in South Florida with a focus on Hispanic patients, 2011-2019. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results